Ed Hernandez
- Democratic
Author
Existing law provides for the licensure and regulation of various health care practitioners by boards and agencies within the Department of Consumer Affairs. Existing law requires a health care practitioner, as defined, to communicate to a patient his or her name, state-granted practitioner license type, and highest level of academic degree, in a specified manner. This bill would require a licensed health care practitioner who performs a stem cell therapy that is not approved by the United States Food and Drug Administration (FDA) to communicate to his or her patient seeking stem cell therapy specified information regarding the provision of stem cell therapies on a specified notice in a prominent display in an area visible to patients in his or her office, posted conspicuously in the entrance of his or her office, and provided in writing to the patient prior to providing the initial stem cell therapy. The bill would not apply to a health care practitioner who has obtained approval for an investigational new drug or device from the FDA for the use of human cells, tissues, or cellular or tissue-based products. The bill would authorize the licensing board having jurisdiction of the health care practitioner to cite and fine the health care practitioner, not to exceed $1,000 per violation, as specified. The bill would require the Medical Board of California to indicate specific enforcement information in its annual report, commencing with the 2018–19 annual report, with regard to its licensees who provide stem cell therapies.
Approved by the Governor.
Chaptered by Secretary of State. Chapter 428, Statutes of 2017.
Enrolled and presented to the Governor at 5:30 p.m.
Assembly amendments concurred in. (Ayes 40. Noes 0. Page 2903.) Ordered to engrossing and enrolling.
Ordered to special consent calendar.
From committee: That the Assembly amendments be concurred in. (Ayes 9. Noes 0. Page 2539.)
Set for hearing September 6.
From committee: Be re-referred to Com. on B., P. & E.D. pursuant to Senate Rule 29.10(d). (Ayes 5. Noes 0.) Re-referred to Com. on B., P. & E.D.
Re-referred to Com. on RLS. pursuant to Senate Rule 29.10(d).
Read third time. Passed. (Ayes 73. Noes 0. Page 2854.) Ordered to the Senate.
In Senate. Concurrence in Assembly amendments pending.
Read second time. Ordered to consent calendar.
From committee: Do pass. Ordered to consent calendar. (Ayes 15. Noes 0.) (August 23).
From committee with author's amendments. Read second time and amended. Re-referred to Com. on APPR.
Read second time and amended. Re-referred to Com. on APPR.
From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 16. Noes 0.) (July 11).
Read second time and amended. Re-referred to Com. on B. & P.
From committee: Do pass as amended and re-refer to Com. on B. & P. (Ayes 15. Noes 0.) (June 20).
From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
In Assembly. Read first time. Held at Desk.
Read third time. Passed. (Ayes 38. Noes 0. Page 990.) Ordered to the Assembly.
Read second time. Ordered to third reading.
From committee: Do pass. (Ayes 8. Noes 0. Page 974.) (May 3).
Set for hearing May 3.
From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS.
From printer. May be acted upon on or after March 19.
Introduced. Read first time. To Com. on RLS. for assignment. To print.
| Bill Text Versions | Format |
|---|---|
| SB512 | HTML |
| 02/16/17 - Introduced | |
| 04/17/17 - Amended Senate | |
| 06/12/17 - Amended Assembly | |
| 06/22/17 - Amended Assembly | |
| 07/17/17 - Amended Assembly | |
| 08/21/17 - Amended Assembly | |
| 09/19/17 - Enrolled | |
| 10/02/17 - Chaptered |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the California State Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.